Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential
Yuchen Yang,
No information about this author
Congmin Xia,
No information about this author
Chuanhui Yao
No information about this author
et al.
Autoimmunity Reviews,
Journal Year:
2025,
Volume and Issue:
24(5), P. 103775 - 103775
Published: Feb. 13, 2025
Rheumatoid
Arthritis
(RA)
is
a
persistent
autoimmune
inflammatory
disorder
that
arises
from
the
intricate
interaction
between
genetic
predisposition
and
environmental
influences.
The
progression
of
RA
can
be
delineated
into
four
distinct
phases:
initially,
influence
risk
factors;
followed
by
emergence
systemic
autoimmunity;
subsequently,
an
asymptomatic
phase;
ultimately,
manifestation
clinical
arthritis.
Recently,
role
mucosal
immunity
in
has
gained
significant
attention
research.
Evidence
published
studies
suggests
not
only
influences
onset
but
also
plays
crucial
its
progression.
Scholars
have
begun
to
unravel
links
barriers
gastrointestinal
tract,
respiratory
system,
oral
cavity.
Specifically,
shifts
microbiota,
dysfunction
barriers,
abnormal
activation
immune
tissues
are
all
implicated
pathogenesis
RA.Despite
this
growing
body
knowledge,
comprehensive
review
therapeutic
implications
yet
conducted.
This
emphasizes
driving
abnormalities
development
autoimmunity
rheumatoid
arthritis
(RA).
It
further
explores
potential
RA,
as
well
issues
challenges
need
addressed
current
research
field,
providing
new
perspective
targets
for
prevention
treatment
RA.
Language: Английский
Exploring the Benefits and Prescribing Informations of Combining East Asian Herbal Medicine with Conventional Medicine in the Treatment of Rheumatoid Arthritis: A Systematic Review and Multifaceted Analysis of 415 Randomized Controlled Trials
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107616 - 107616
Published: Jan. 1, 2025
Notwithstanding
progress
in
conventional
medicine
(CM),
the
management
of
rheumatoid
arthritis
(RA)
continues
to
be
problematic
due
factors
such
as
limited
patient
response
treatment
and
restricted
medication
access.
This
study
aimed
evaluate
extent
which
East
Asian
herbal
with
CM
combination
therapy
(EACM)
provides
additional
benefits
effectiveness
safety.
We
conducted
a
comprehensive
search
across
11
databases
English,
Chinese,
Korean,
Japanese
for
randomized
controlled
trials.
The
review
followed
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
guidelines,
using
American
College
Rheumatology
(ACR)
20/50/70
Response
Criteria
incidence
adverse
events
(AEI)
primary
outcomes.
meta-analysis
was
performed
random-effects
model.
quality
each
assessed
according
RoB
2.
Of
1,036
full-text
articles
screened,
415
were
included
review.
data
from
37,839
participants.
EACM
associated
higher
ACR
responses:
20
(RR:
1.2332;
95%
CI:
1.1852
1.2831,
p
<
0.0001),
50
1.3782;
1.2936
1.4684,
70
1.7084;
1.5555
1.8762,
well
favorable
AEI
(OR:
0.3977;
0.3476
0.4551,
indicating
both
better
efficacy
safety
compared
alone.
These
patterns
consistent
eight
secondary
outcomes
measuring
pain,
inflammation,
disease
activity
RA.
Subgroup
analyses
showed
that
EACM's
effects
independent
control
type.
Through
analysis
polyherbal
prescription
dataset,
we
identified
18
key
herbs
16
significant
rules,
further
supported
by
relevant
preclinical
evidence.
synergistic
combinations
anticipated
most
pharmacologically
influential
contributing
outcomes,
substantiated
analytical
metrics
including
network
topology
intricate
association
pattern
evaluations.
findings
suggest
may
serve
valuable
complementary
strategy
RA
patients
insufficiently
managed
In
particular,
given
index
integrates
multiple
aspects
patients,
results
are
expected
provide
decision
support
who
do
not
respond
therapy,
medical
economic
reasons.
Additionally,
derived
through
multifaceted
analysis,
actively
reflect
clinicians'
implicit
preferences
prescribing
EACMs,
important
hypotheses
research
clinical
application.
However,
qualitative
quantitative
improvements
needed
more
definitive
conclusions.
Further
prescriptions
presented
this
will
direction
future
research.
Language: Английский
Chemical composition and in vitro intestinal probiotic properties analysis of exopolysaccharides from screened Streptococcus thermophilus 90301
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
311, P. 143882 - 143882
Published: May 2, 2025
Language: Английский
Unlocking the power of short-chain fatty acids in ameliorating intestinal mucosal immunity: a new porcine nutritional approach
Haoyang Liu,
No information about this author
Hongde Lu,
No information about this author
Yuxuan Wang
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 2, 2024
Short-chain
fatty
acids
(SCFAs),
a
subset
of
organic
with
carbon
chains
ranging
from
one
to
six
atoms
in
length,
encompass
acetate,
propionate,
and
butyrate.
These
compounds
are
the
endproducts
dietary
fiber
fermentation,
primarily
catalyzed
by
glycolysis
pentose
phosphate
pathways
within
gut
microbiota.
SCFAs
act
as
pivotal
energy
substrates
signaling
molecules
realm
animal
nutrition,
exerting
profound
influence
on
intestinal,
immune
system,
intestinal
barrier
functions.
Specifically,
they
contibute
60-70%
total
requirements
ruminants
10-25%
monogastric
animals.
have
demonstrated
capability
effectively
modulate
pH,
optimize
absorption
mineral
elements,
impede
pathogen
invasion.
Moreover,
enhance
expression
proteins
associated
tight
junctions
stimulate
mucus
production,
thereby
refining
tissue
morphology
preserving
integrity
structure.
Notably,
also
exert
anti-inflammatory
properties,
mitigating
inflammation
epithelium
strengthening
barrier’s
defensive
capabilities.
The
present
review
endeavors
synthesize
recent
findings
regarding
role
crucial
intermediaries
between
metabolic
activities
microbiota
status
porcine
cells.
It
provides
comprehensive
overview
current
literature
SCFAs’
impact
responses
mucosa.
Language: Английский